Skip to content

Insider · CIK 0001748622

Bhatt Elizabeth

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

Transactions

46

Companies

4

Filings

7

CIK

0001748622

Forms 4 and 5

Insider transactions

46 trades
DateCompanyValue
2026-08-11SEPNSepterna, Inc.M Exercise/Conversion+$127K
2026-08-11SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2026-08-11SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2026-08-11SEPNSepterna, Inc.S Sale−$1.1M
2026-08-11SEPNSepterna, Inc.M Exercise/Conversion+$17.4K
2026-07-15SEPNSepterna, Inc.S Sale−$136K
2026-07-15SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2026-07-15SEPNSepterna, Inc.M Exercise/Conversion+$27.2K
2026-04-15SEPNSepterna, Inc.S Sale−$61.1K
2026-04-15SEPNSepterna, Inc.S Sale−$8,431.11
2026-04-15SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2026-04-15SEPNSepterna, Inc.S Sale−$27.8K
2026-04-15SEPNSepterna, Inc.M Exercise/Conversion+$27.2K
2026-02-18SEPNSepterna, Inc.S Sale−$53.2K
2026-02-18SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2026-02-18SEPNSepterna, Inc.S Sale−$62.6K
2026-02-18SEPNSepterna, Inc.M Exercise/Conversion+$27.2K
2026-02-06SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award—
2025-08-07SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award—
2024-06-13eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2024-02-19eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2023-06-22eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2023-01-20eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2022-06-09eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2022-02-15Applied Molecular Transport Inc.A Award—
2022-02-15Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award—
2021-12-24Applied Molecular Transport Inc.A Award—
2021-10-06eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2021-08-25eFFECTOR Therapeutics, Inc.Class B Common StockD Disposition to Issuer—
2021-08-25eFFECTOR Therapeutics, Inc.Class B Common StockC Conversion—
2021-08-25eFFECTOR Therapeutics, Inc.C Conversion—
2021-07-21Applied Molecular Transport Inc.S Sale−$88.3K
2021-07-21Applied Molecular Transport Inc.M Exercise/Conversion+$41.5K
2021-07-21Applied Molecular Transport Inc.S Sale−$242K
2021-07-21Applied Molecular Transport Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2021-04-21Applied Molecular Transport Inc.S Sale−$219K
2021-04-21Applied Molecular Transport Inc.S Sale−$108K
2021-04-21Applied Molecular Transport Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2021-04-21Applied Molecular Transport Inc.M Exercise/Conversion+$41.5K
2021-04-21Applied Molecular Transport Inc.S Sale−$38.2K
2021-03-01Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award—
2021-01-12eFFECTOR Therapeutics, Inc.Class B Common StockJ Other—
2019-02-21Achaogen, Inc.S Sale−$864.19
2019-01-18Achaogen, Inc.A Award—
2018-10-31Achaogen, Inc.A Award—
2018-09-11Achaogen, Inc.Stock Option (Right to Buy)A Award—

Recent filings

7